$ELOX Eloxx Pharmaceuticals, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Eloxx Pharmaceuticals, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Eloxx Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Eloxx Pharmaceuticals, Inc. for free.

CIK Number: 0001035354
IRS Number: 841368850
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Trading Symbol: ELOX
Company Address: 950 WINTER STREET WALTHAM 02451
Phone number: 858-909-0749
Former name: NAVA LEISURE USA INC, date of change: 1997-03-10
Former name: SENESCO TECHNOLOGIES INC, date of change: 1999-10-06
Former name: Sevion Therapeutics, Inc., date of change: 2014-09-30

Market Capitalization: $4.75M
Prev close: $0.23
Average Daily Volume: 35,194
Days Low: $0.00
Year Low: $0.08
Year High: $0.39

Eloxx Pharmaceuticals, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Ward RobertCHIEF EXECUTIVE OFFICER131,15630,166shares bought: 264,194 / shares sold: -143,505 STRONG BUYMar 28 20192 months ago

View all Eloxx Pharmaceuticals, Inc. insiders.

Eloxx Pharmaceuticals, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 28 2019ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...Option ExerciseM0.0035,5990391,591
Mar 28 2019ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...Payment of ExerciseF11.5010,467120,371120,689131.2 K to 120.7 K (-7.98 %)
Mar 28 2019ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...BuyM0.0035,5990131,15695.6 K to 131.2 K (+37.25 %)
Jan 31 2019ELOXEloxx Pharmaceutic ...Snow David P.CHIEF BUSINESS OFFI ...Option ExerciseA0.0025,000025,000
Jan 31 2019ELOXEloxx Pharmaceutic ...Snow David P.CHIEF BUSINESS OFFI ...Option ExerciseA11.5355,000634,15055,000
Jan 31 2019ELOXEloxx Pharmaceutic ...Belloff Neil S.GENERAL COUNSEL/COR ...Option ExerciseA0.0025,000025,000
Jan 31 2019ELOXEloxx Pharmaceutic ...Belloff Neil S.GENERAL COUNSEL/COR ...Option ExerciseA11.5350,000576,50050,000
Jan 31 2019ELOXEloxx Pharmaceutic ...WEAVER GREGORY LCHIEF FINANCIAL OFF ...Option ExerciseA0.0020,000020,000
Jan 31 2019ELOXEloxx Pharmaceutic ...WEAVER GREGORY LCHIEF FINANCIAL OFF ...Option ExerciseA11.5360,000691,80060,000
Jan 31 2019ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...Option ExerciseA11.53226,0002,605,780226,000
Jan 31 2019ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF OPERATING OFF ...Option ExerciseA0.0030,000030,000
Jan 31 2019ELOXEloxx Pharmaceutic ...Williams Gregory C.CHIEF OPERATING OFF ...Option ExerciseA11.53100,0001,153,000100,000
Dec 28 2018ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...Option ExerciseM0.00213,5950427,190
Dec 28 2018ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...GiftG0.0050,000095,557145.6 K to 95.6 K (-34.35 %)
Dec 28 2018ELOXEloxx Pharmaceutic ...Ward RobertCHIEF EXECUTIVE OFF ...Payment of ExerciseF12.6083,0381,046,279145,557228.6 K to 145.6 K (-36.33 %)

View all Eloxx Pharmaceuticals, Inc. insider transactions.